The parallel lives of angiogenesis and immunosuppression: cancer and other tales
The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Emerging evidence indicates that angiogenesis and immunosuppression frequently occur simultaneously in response to diverse stimuli. Here, we describe a fundamental biological programme that involves the activation of both angiogenesis and immunosuppressive responses, often through the same cell types or soluble factors. We suggest that the initiation of these responses is part of a physiological and homeostatic tissue repair programme, which can be co-opted in pathological states, notably by tumours. This view can help to devise new cancer therapies and may have implications for aseptic tissue injury, pathogen-mediated tissue destruction, chronic inflammation and even reproduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunosuppression promoted by tumor angiogenesis, and more immune cells are related with angiogenesis [156].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [156]
In the citing paper
“Angiogenesis is significantly correlated with tumor progression and is an important part of the formation of the immunosuppressive microenvironment in osteosarcoma.”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [156]
Citations
Cites
1 retracted
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling
Zanin-Zhorov, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28423 · Cited by 323
RetractedTumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“However, IL-6 can also promote the differentiation of T H 17 cells over T Reg cell”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citationKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Self-citationTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., & Dazzi, F. (2003) · Blood · doi:10.1182/blood-2002-07-2104 · Cited by 1,598
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Self-citationBlockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lönnies, H., Marschall, H.-U., Dlugosz, A., Szakos, A., Hassan, Z., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000214462.63943.14 · Cited by 1,142
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
In Search of the In Vivo Identity of Mesenchymal Stem Cells
da Silva Meirelles, L., Caplan, A. I., & Nardi, N. B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1122 · Cited by 1,077
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Escudier, B., Bellmunt, J., Négrier, S., Bajetta, E., Melichar, B., Bracarda, S., Ravaud, A., Golding, S., Jethwa, S., & Sneller, V. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7849 · Cited by 800
Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction
Nahrendorf, M., Pittet, M. J., & Swirski, F. K. (2010) · Circulation · doi:10.1161/circulationaha.109.916346 · Cited by 799
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 792
Rini, B. I., Halabi, S., Rosenberg, J. E., Stadler, W. M., Vaena, D. A., Archer, L., Atkins, J. N., Picus, J., Czaykowski, P., Dutcher, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5561 · Cited by 787
Toll-like receptor 2 controls expansion and function of regulatory T cells
Sutmuller, R. P. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25439 · Cited by 756
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748 · cited 1×
“and/or to promote immunosuppression through the induction of immunosuppressive molecules such as B7H4 (also known as VTCN1”
BackgroundLasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 739
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
Mechanisms of Leukocyte Transendothelial Migration
Muller, W. A. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130224 · Cited by 625
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
Baratelli, F., Lin, Y., Zhu, L., Yang, S.-C., Heuzé-Vourc’h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., & Dubinett, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1483 · Cited by 573
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Detmar, M., Brown, L. F., Schön, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., & Jain, R. K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00262.x · Cited by 550
De Palma, M., Venneri, M. A., Roca, C., & Naldini, L. (2003) · Nature Medicine · doi:10.1038/nm871 · Cited by 549
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Self-citationVEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
Ohm, J. E., Gabrilovich, D. I., Sempowski, G. D., Kisseleva, E., Parman, K. S., Nadaf, S., & Carbone, D. P. (2003) · Blood · doi:10.1182/blood-2002-07-1956 · Cited by 538
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Lai, K.-B., Lee, C.-N., & Hsieh, C.-Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206226 · Cited by 536
Zarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515
TGF-? receptor function in the endothelium
LEBRIN, F., DECKERS, M., BERTOLINO, P., & TENDIJKE, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.036 · Cited by 513
CD99 plays a major role in the migration of monocytes through endothelial junctions
Schenkel, A. R., Mamdouh, Z., Chen, X., Liebman, R. M., & Muller, W. A. (2002) · Nature Immunology · doi:10.1038/ni749 · Cited by 509
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis
Rodig, N., Ryan, T., Allen, J. A., Pang, H., Grabie, N., Chernova, T., Greenfield, E. A., Liang, S. C., Sharpe, A. H., Lichtman, A. H., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324270 · Cited by 492
Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902280106 · Cited by 471
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446
Conejo-Garcia, J. R., Benencia, F., Courreges, M.-C., Kang, E., Mohamed-Hadley, A., Buckanovich, R. J., Holtz, D. O., Jenkins, A., Na, H., Zhang, L., et al. (2004) · Nature Medicine · doi:10.1038/nm1097 · Cited by 437
Self-citationSelective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M., Kerr, B. A., Borden, E. C., Podrez, E. A., Salomon, R. G., & Byzova, T. V. (2010) · Nature · doi:10.1038/nature09421 · Cited by 431
Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., Van Damme, J., & Mantovani, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.762 · Cited by 426
B Cell-Driven Lymphangiogenesis in Inflamed Lymph Nodes Enhances Dendritic Cell Mobilization
Angeli, V., Ginhoux, F., Llodrà, J., Quemeneur, L., Frenette, P. S., Skobe, M., Jessberger, R., Merad, M., & Randolph, G. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.003 · Cited by 424
B cells inhibit induction of T cell-dependent tumor immunity
Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 419
Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C. L., Söker, S., Niknejad, K., Peoples, G. E., & Klagsbrun, M. (1995) · PubMed · Cited by 393
Sarris, M., Andersen, K. G., Randow, F., Mayr, L., & Betz, A. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.012 · Cited by 359
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
An overview of small-molecule inhibitors of VEGFR signaling
Ivy, S. P., Wick, J. Y., & Kaufman, B. M. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.130 · Cited by 350
Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., & Stern, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11463 · Cited by 345
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., & Saito, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13119 · Cited by 338
Inhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., & De Palma, M. (2009) · Blood · doi:10.1182/blood-2009-01-200931 · Cited by 328
B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis
Mazanet, M. M., & Hughes, C. C. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3581 · Cited by 326
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Dirkx, A. E. M., oude Egbrink, M. G. A., Wagstaff, J., & Griffioen, A. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905495 · Cited by 326
Dirkx, A. E. M., Egbrink, M. G. A. O., Kuijpers, M. J. E., van der Niet, S. T., Heijnen, V. V. T., Steege, J. C. A. B.-T., Wagstaff, J., & Griffioen, A. W. (2003) · PubMed · Cited by 325
Griffioen, A., Damen, C., Blijham, G., & Groenewegen, G. (1996) · Blood · doi:10.1182/blood.v88.2.667.bloodjournal882667 · Cited by 304
Manicassamy, S., Ravindran, R., Deng, J., Oluoch, H., Denning, T. L., Kasturi, S. P., Rosenthal, K. M., Evavold, B. D., & Pulendran, B. (2009) · Nature Medicine · doi:10.1038/nm.1925 · Cited by 302
Hypoxia-Induced Gene Expression in Human Macrophages
Burke, B., Giannoudis, A., Corke, K. P., Gill, D., Wells, M., Ziegler-Heitbrock, L., & Lewis, C. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63483-9 · Cited by 286
Griffioen, A. W., Damen, C. A., Martinotti, S., Blijham, G. H., & Groenewegen, G. (1996) · PubMed · Cited by 282
Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality
Yano, K., Liaw, P. C., Mullington, J. M., Shih, S.-C., Okada, H., Bodyak, N., Kang, P. M., Toltl, L., Belikoff, B., Buras, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060375 · Cited by 279
Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice
Stabile, E., Burnett, M. S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., Miller, J. M., Shou, M., Epstein, S. E., & Fuchs, S. (2003) · Circulation · doi:10.1161/01.cir.0000079225.50817.71 · Cited by 268
Inhibition of Angiogenesis by Interleukin 4
Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., & Bouck, N. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1039 · Cited by 255
Chinnasamy, D., Yu, Z., Theoret, M. R., Zhao, Y., Shrimali, R. K., Morgan, R. A., Feldman, S. A., Restifo, N. P., & Rosenberg, S. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43490 · Cited by 253
Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway
Lu, L., Ikizawa, K., Hu, D., Werneck, M. B. F., Wucherpfennig, K. W., & Cantor, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.017 · Cited by 253
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Mechanisms of Disease: angiogenesis in inflammatory diseases
Szekanecz, Z., & Koch, A. E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0647 · Cited by 239
Wakita, D., Sumida, K., Iwakura, Y., Nishikawa, H., Ohkuri, T., Chamoto, K., Kitamura, H., & Nishimura, T. (2010) · European Journal of Immunology · doi:10.1002/eji.200940157 · Cited by 236
Li, B., Lalani, A. S., Harding, T. C., Luan, B., Koprivnikar, K., Huan Tu, G., Prell, R., VanRoey, M. J., Simmons, A. D., & Jooss, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1558 · Cited by 232
Huang, Y., Chen, X., Dikov, M. M., Novitskiy, S. V., Mosse, C. A., Yang, L., & Carbone, D. P. (2007) · Blood · doi:10.1182/blood-2007-01-065714 · Cited by 230
Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver disease
Halder, R. C., Aguilera, C., Maricic, I., & Kumar, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31602 · Cited by 226
Quezada, S. A., Peggs, K. S., Simpson, T. R., Shen, Y., Littman, D. R., & Allison, J. P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080099 · Cited by 218
Sata, M., & Walsh, K. (1998) · Nature Medicine · doi:10.1038/nm0498-415 · Cited by 215
Ohta, A., Ohta, A., Madasu, M., Kini, R., Subramanian, M., Goel, N., & Sitkovsky, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901247 · Cited by 215
Kalkunte, S. S., Mselle, T. F., Norris, W. E., Wira, C. R., Sentman, C. L., & Sharma, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803769 · Cited by 207
Bagnato, A., Salani, D., Castro, V. D., et al. (1999) · PubMed · Cited by 207
Bottazzi, B., Walter, S., Govoni, D., Colotta, F., & Mantovani, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1280 · Cited by 202
Bouzin, C., Brouet, A., De Vriese, J., DeWever, J., & Feron, O. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1505 · Cited by 200
Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions
Imanishi, T., Hara, H., Suzuki, S., Suzuki, N., Akira, S., & Saito, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6715 · Cited by 200
T L ymphocyte –E ndothelial C ell I nteractions
Choi, J., Enis, D. R., Koh, K. P., Shiao, S. L., & Pober, J. S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104639 · Cited by 195
Vascular leukocytes contribute to tumor vascularization
Conejo-Garcia, J. R., Buckanovich, R. J., Benencia, F., Courreges, M. C., Rubin, S. C., Carroll, R. G., & Coukos, G. (2005) · Blood · doi:10.1182/blood-2004-05-1906 · Cited by 184
Self-citationEubank, T. D., Galloway, M., Montague, C. M., Waldman, W. J., & Marsh, C. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2637 · Cited by 173
Shetty, S., Weston, C. J., Oo, Y. H., Westerlund, N., Stamataki, Z., Youster, J., Hubscher, S. G., Salmi, M., Jalkanen, S., Lalor, P. F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002961 · Cited by 173
Riesenberg, R., Weiler, C., Spring, O., Eder, M., Buchner, A., Popp, T., Castro, M., Kammerer, R., Takikawa, O., Hatz, R. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0942 · Cited by 170
Review of the activation of TGF-β in immunity
Taylor, A. W. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708415 · Cited by 169
Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
Muthuswamy, R., Urban, J., Lee, J.-J., Reinhart, T. A., Bartlett, D., & Kalinski, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6818 · Cited by 162
Wound Healing Is Impaired in MyD88-Deficient Mice
Macedo, L., Pinhal‐Enfield, G., Alshits, V., Elson, G., Cronstein, B. N., & Leibovich, S. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061048 · Cited by 158
Huang, X., Bai, X., Cao, Y., Wu, J., Huang, M., Tang, D., Tao, S., Zhu, T., Liu, Y., Yang, Y., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090397 · Cited by 156
Immunotherapy for Ovarian Cancer: What's Next?
Kandalaft, L. E., Powell, D. J., Singh, N., & Coukos, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2369 · Cited by 154
Self-citationA Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Li, X., Loberg, R. D., Liao, J., Chi, Y., Snyder, L. A., Pienta, K. J., & McCauley, L. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2164 · Cited by 153
Ishida, T., Oyama, T., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4842 · Cited by 150
Oldford, S. A., Haidl, I. D., Howatt, M., Leiva, C., Johnston, B., & Marshall, J. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001137 · Cited by 148
Endothelium-derived factors as paracrine mediators of prostate cancer progression
Pirtskhalaishvili, G., & Nelson, J. B. (2000) · The Prostate · doi:10.1002/1097-0045(20000615)44:1<61::aid-pros9>3.0.co;2-3 · Cited by 145
Endothelium-derived factors as paracrine mediators of prostate cancer progression
Pirtskhalaishvili, G., & Nelson, J. B. (2000) · The Prostate · Cited by 142
Jarnicki, A., Conroy, H., Brereton, C. F., Donnelly, G., Toomey, D., Walsh, K., Sweeney, C. M., Leavy, O., Fletcher, J. M., Lavelle, E. C., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3797 · Cited by 137
Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma
Nummer, D., Suri‐Payer, E., Schmitz‐Winnenthal, H., Bonertz, A., Galindo, L., Antolovic, D., Koch, M., Büchler, M., Weitz, J., Schirrmacher, V., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm064 · Cited by 137
VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
Suzuki, H. Y., Onishi, H., 和田, 純., Yamasaki, A., Tanaka, H., Nakano, K., Morisaki, T., & Katano, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939887 · Cited by 136
Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells
Riboldi, E., Musso, T., Moroni, E., Urbinati, C., Bernasconi, S., Rusnati, M., Adorini, L., Presta, M., & Sozzani, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2788 · Cited by 134
Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO
Basu, G. D., Tinder, T. L., Bradley, J. M., Tu, T., Hattrup, C. L., Pockaj, B. A., & Mukherjee, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2391 · Cited by 133
Cavassani, K. A., Carson, W. F., Serezani, A. P. M., Wen, H., Schaller, M. A., Ishii, M., Lindell, D. M., Dou, Y., Lukacs, N. W., Keshamouni, V. G., et al. (2010) · Blood · doi:10.1182/blood-2009-09-241083 · Cited by 133
Min, J., Lee, Y., Kim, J. H., Kim, Y., Kim, S. W., Lee, S.-Y., Gho, Y. S., Oh, G. T., & Kwon, Y. (2005) · Circulation Research · doi:10.1161/01.res.0000155330.07887.ee · Cited by 132
The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13
Fukushi, J., Ono, M., Morikawa, W., Iwamoto, Y., & Kuwano, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2818 · Cited by 130
Montesinos, M. C., Shaw, J. P., Yee, H. T., Shamamian, P. E., & Cronstein, B. N. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63749-2 · Cited by 128
Gupta, S., Joshi, K., Wig, J. D., & Arora, S. K. (2007) · Acta Oncologica · doi:10.1080/02841860701233443 · Cited by 123
Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H., & Matsumoto, Y. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0466-8 · Cited by 117
Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo
Biancone, L., Martino, A. D., Orlandi, V. T., Conaldi, P. G., Toniolo, A., & Camussi, G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.147 · Cited by 117
Chamorro, S., García-Vallejo, J. J., Unger, W. W. J., Fernandes, R. J., Bruijns, S. C. M., Laban, S., Roep, B. O., Hart, B. A. ‘., & van Kooyk, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801155 · Cited by 116
Giatromanolaki, A. N., Bates, G. J., Koukourakis, M. I., Sivridis, E., Gatter, K. C., Harris, A. L., & Banham, A. H. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.021 · Cited by 108
Spinella, F., Rosanò, L., Castro, V. D., Natali, P. G., & Bagnato, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408584200 · Cited by 106
Ahmadi, M., Emery, D. C., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1060 · Cited by 105
Okazaki, T., Ebihara, S., Asada, M., Kanda, A., Sasaki, H., & Yamaya, M. (2005) · International Immunology · doi:10.1093/intimm/dxh334 · Cited by 104
Porta, M. G. D., Danova, M., Rigolin, G. M., Brugnatelli, S., Rovati, B., Tronconi, M. C., Fraulini, C., Rossi, A. R., Riccardi, A., & Castoldi, G. (2005) · Oncology · doi:10.1159/000086784 · Cited by 91
Shrestha, B., Hashiguchi, T., Ito, T. K., Miura, N., Takenouchi, K., Oyama, Y., Kawahara, K., Tancharoen, S., Kii, Y., Arimura, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903063 · Cited by 89
Local Expression of Indoleamine 2,3-Dioxygenase Protects Engraftment of Xenogeneic Skin Substitute
Li, Y., Tredget, E. E., Ghaffari, A., Lin, X., Kilani, R. T., & Ghahary, A. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700022 · Cited by 87
Imaging Correlates of Differential Expression of Indoleamine 2,3-Dioxygenase in Human Brain Tumors
Batista, C. E. A., Juhász, C., Muzik, O., Kupsky, W. J., Barger, G. R., Chugani, H. T., Mittal, S., Sood, S., Chakraborty, P. K., & Chugani, D. C. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0225-0 · Cited by 75
Bourbié-Vaudaine, S., Blanchard, N., Hivroz, C., & Roméo, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1460 · Cited by 74
Kyriakakis, E., Cavallari, M., Andert, J., Philippova, M., Koella, C., Bochkov, V., Erné, P., Wilson, S. B., Mori, L., Biedermann, B. C., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040619 · Cited by 72
Yamazaki, S., Okada, K., Maruyama, A., Matsumoto, M., Yagita∥, H., & Seya, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018833 · Cited by 67
PGE2 induces angiogenesis via MT1-MMP–mediated activation of the TGFβ/Alk5 signaling pathway
Alfranca, A., López-Oliva, J. M., Genı́s, L., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112268 · Cited by 67
Lin, Y., Liang, Y., & Chiang, B. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307164 · Cited by 67
Ma, L., Mauro, C., Cornish, G. H., Chai, J., Coe, D., Fu, H., Patton, D. T., Okkenhaug, K., Franzoso, G., Dyson, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011748107 · Cited by 67
Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells
Shin, J.-Y., Yoon, I., Kim, J.-S., Kim, B., & Park, C. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.006 · Cited by 65
Regulatory T Cells Negatively Regulate Neovasculature of Airway Remodeling via DLL4-Notch Signaling
Huang, M., Dai, Y.-S., Chou, Y., Juan, Y., Wang, C.-C., & Chiang, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804371 · Cited by 63
Mulligan, J. K., Day, T. A., Gillespie, M. B., Rosenzweig, S. A., & Young, M. R. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.01.014 · Cited by 58
Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration
Steege, J. C. A. B.-T., Baeten, C. I. M., Thijssen, V. L., Satijn, S., Verhoeven, I. C. L., Hillen, H. F. P., Wagstaff, J., & Griffioen, A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0742 · Cited by 55
Tumors induce the formation of suppressor endothelial cells in vivo
Mulligan, J. K., & Young, M. R. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0747-y · Cited by 49
IL-4 Is Proangiogenic in the Lung under Hypoxic Conditions
Yamaji-Kegan, K., Su, Q., Angelini, D. J., & Johns, R. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713347 · Cited by 39
The Puzzling Role of TRAIL in Endothelial Cell Biology
Secchiero, P., & Zauli, G. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158451 · Cited by 15
Cited by
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Arneth, B. (2019) · Medicina · doi:10.3390/medicina56010015 · Cited by 1,250
Garcia, J., Hurwitz, H. I., Sandler, A. B., Miles, D., Coleman, R. L., Deurloo, R., & Chinot, O. L. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102017 · Cited by 1,159
Metadata
- Authors
- Motz, G. T., & Coukos, G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Coukos, George
- ORCID
- Coukos, George
- Venue
- Nature Reviews Immunology
- Published
- 2011-09-23
- Volume
- 11
- Issue
- 10
- Pages
- 702-711
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2052375870
- Semantic Scholar
- 2dea83d1faa8a562a9f968fe17c975b984e123a8
- Cited by
- 481
- References
- 145
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 29 · 2023: 34 · 2022: 46 · 2021: 35 · 2020: 39 · 2019: 42 · 2018: 40 · 2017: 35 · 2016: 31 · 2015: 29 · 2014: 24 · 2013: 29 · 2012: 16
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P01 CA 83638)
- National Institute of Allergy and Infectious Diseases (R01 AI043549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- angiogenesis, immunosuppression, tumor growth, tissue repair, tumor immune evasion, cancer therapy, chronic inflammation, reproduction
- MeSH terms
- Animals, Cell Communication, Homeostasis, Humans, Immune Tolerance, Immunosuppression Therapy, Immunosuppressive Agents, Neoplasm Proteins, Neoplasms, Neovascularization, Pathologic, T-Lymphocyte Subsets, Cytokines, Stromal Cells, Myeloid Cells, Intercellular Signaling Peptides and Proteins, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.